A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523
NCT02105129
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
118
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG:
HMPL-523
DRUG:
Placebo
Sponsor
Hutchison Medipharma Limited